# clm_1330872EE468

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 428,253,000 United States dollar  
valid_from: 2011-09-30  
valid_to: 2011-12-31  
published: 2011-10-27  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_589084C462D0  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 428,253,000 United States dollar", as of 2011-09-30 (until 2011-12-31). Claim clm_1330872EE468, https://asof.is/claim/clm_1330872EE468, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2011, filed 2011-10-27  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677411002300/0001206774-11-002300-index.htm (primary, SEC EDGAR 10-Q Q3 FY2011, published 2011-10-27)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 478,034,000 United States dollar | valid 2011-06-30 to 2011-09-30 | conf 0.95 | superseded | superseded_by [clm_1330872EE468](/claim/clm_1330872EE468.md) | [clm_510855B8D0BD](/claim/clm_510855B8D0BD.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.